Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial

Steven Pascoe; Neil Barnes; Guy Brusselle; Chris Compton; Gerard J. Criner; Mark T. Dransfield; David M. G. Halpin; MeiLan K. Han; Benjamin Hartley; Peter Lange; Sally Lettis; David A. Lipson; David A. Lomas; Fernando J. Martinez; Alberto Papi; Nicolas Roche; Ralf J. P. van der Valk; Robert Wise; Dave Singh

doi:10.1016/S2213-2600(19)30190-0

Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial

Steven Pascoe, Neil Barnes, Guy Brusselle, Chris Compton, Gerard J. Criner, Mark T. Dransfield, David M. G. Halpin, MeiLan K. Han, Benjamin Hartley, Peter Lange, Sally Lettis, David A. Lipson, David A. Lomas, Fernando J. Martinez, Alberto Papi, Nicolas Roche, Ralf J. P. van der Valk, Robert Wise, Dave Singh

57 Citations (Scopus)

Original language	English
Journal	The Lancet Respiratory Medicine
Volume	7
Issue number	9
Pages (from-to)	745-756
Number of pages	12
ISSN	2213-2600
DOIs	https://doi.org/10.1016/S2213-2600(19)30190-0
Publication status	Published - Sept 2019

Access to Document

10.1016/S2213-2600(19)30190-0

Cite this

Pascoe, S., Barnes, N., Brusselle, G., Compton, C., Criner, G. J., Dransfield, M. T., Halpin, D. M. G., Han, M. K., Hartley, B., Lange, P., Lettis, S., Lipson, D. A., Lomas, D. A., Martinez, F. J., Papi, A., Roche, N., van der Valk, R. J. P., Wise, R., & Singh, D. (2019). Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial. The Lancet Respiratory Medicine, 7(9), 745-756. https://doi.org/10.1016/S2213-2600(19)30190-0

Pascoe, S, Barnes, N, Brusselle, G, Compton, C, Criner, GJ, Dransfield, MT, Halpin, DMG, Han, MK, Hartley, B, Lange, P, Lettis, S, Lipson, DA, Lomas, DA, Martinez, FJ, Papi, A, Roche, N, van der Valk, RJP, Wise, R & Singh, D 2019, 'Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial', The Lancet Respiratory Medicine, vol. 7, no. 9, pp. 745-756. https://doi.org/10.1016/S2213-2600(19)30190-0

@article{fb39b6a5d5164ab49ebf2b7548526bfe,

title = "Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial",

author = "Steven Pascoe and Neil Barnes and Guy Brusselle and Chris Compton and Criner, {Gerard J.} and Dransfield, {Mark T.} and Halpin, {David M. G.} and Han, {MeiLan K.} and Benjamin Hartley and Peter Lange and Sally Lettis and Lipson, {David A.} and Lomas, {David A.} and Martinez, {Fernando J.} and Alberto Papi and Nicolas Roche and {van der Valk}, {Ralf J. P.} and Robert Wise and Dave Singh",

year = "2019",

month = sep,

doi = "10.1016/S2213-2600(19)30190-0",

language = "English",

volume = "7",

pages = "745--756",

journal = "The Lancet Respiratory Medicine",

issn = "2213-2600",

publisher = "The Lancet Publishing Group",

number = "9",

}

TY - JOUR

T1 - Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial

AU - Pascoe, Steven

AU - Barnes, Neil

AU - Brusselle, Guy

AU - Compton, Chris

AU - Criner, Gerard J.

AU - Dransfield, Mark T.

AU - Halpin, David M. G.

AU - Han, MeiLan K.

AU - Hartley, Benjamin

AU - Lange, Peter

AU - Lettis, Sally

AU - Lipson, David A.

AU - Lomas, David A.

AU - Martinez, Fernando J.

AU - Papi, Alberto

AU - Roche, Nicolas

AU - van der Valk, Ralf J. P.

AU - Wise, Robert

AU - Singh, Dave

PY - 2019/9

Y1 - 2019/9

U2 - 10.1016/S2213-2600(19)30190-0

DO - 10.1016/S2213-2600(19)30190-0

M3 - Journal article

SN - 2213-2600

VL - 7

SP - 745

EP - 756

JO - The Lancet Respiratory Medicine

JF - The Lancet Respiratory Medicine

IS - 9

ER -

Blood eosinophils and treatment response with triple and dual combination therapy in chronic obstructive pulmonary disease: analysis of the IMPACT trial

Access to Document

Fingerprint

Cite this